New Blood Test Predicts Stroke Risk with High Accuracy

Researchers develop a blood test that quantifies stroke risk by measuring inflammatory molecules, potentially transforming stroke prevention.

A UCLA study introduces a blood test that measures inflammatory molecules to predict stroke and cognitive decline risk.
The test uses a biomarker network known as IL-18, associated with cerebral small vessel disease, a common stroke cause.
Researchers utilized data from the Framingham Heart Study, showing those with high biomarker levels had an 84% lifetime stroke risk.
Current methods, like the Framingham Stroke Risk Profile, lack the precision this new test could offer in clinical settings.
Further research is needed to understand if and how an individual's risk score can be modified to prevent strokes.